oleandomycin
Oleandomycin is a macrolide antibiotic. It is synthesized from strains of Streptomyces antibioticus. It is weaker than erythromycin.
Key facts
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 447815338
- Drug.IUPAC_name
- (3R,5R,6S,7R,8R,11R,12S,13R,14S,15S)-14-((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6-hydroxy-12-((2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yloxy)-5,7,8,11,13,15-hexamethyl-1,9-dioxaspiro[2.13]hexadecane-4,10-dione
- Drug.image
- Oleandomycin.svg
- Drug.image_class
- skin-invert-image
- Drug.CAS_number
- 3922-90-5
- Drug.ATC_prefix
- J01
- Drug.ATC_suffix
- FA05
- Drug.PubChem
- 5284598
- Drug.ChEMBL
- 606258
- Drug.ChemSpiderID
- 4447646
- Drug.UNII
Article
12 sectionsContents
- Medical uses
- Pharmacology
- Mechanism of action
- Relative strength
- Chemistry
- Polyketide biosynthesis
- Post-PKS modifications
- History
- Sigmamycine combination drug
- Society and culture
- Brand names
- References
Oleandomycin is a macrolide antibiotic. It is synthesized from strains of Streptomyces antibioticus. It is weaker than erythromycin.
It used to be sold under the brand name Sigmamycine, combined with tetracycline, and made by the company Rosa-Phytopharma in France.